These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31362063)

  • 1. The human adrenal gland as a drug metabolizer: First in-vivo evidence for the conversion of steroidal drugs.
    Hartmann MF; Reincke M; Wudy SA; Bernhardt R
    J Steroid Biochem Mol Biol; 2019 Nov; 194():105438. PubMed ID: 31362063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.
    Schiffer L; Müller AR; Hobler A; Brixius-Anderko S; Zapp J; Hannemann F; Bernhardt R
    J Steroid Biochem Mol Biol; 2016 Oct; 163():68-76. PubMed ID: 27125452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional maturation of the primate fetal adrenal in vivo: 3. Specific zonal localization and developmental regulation of CYP21A2 (P450c21) and CYP11B1/CYP11B2 (P450c11/aldosterone synthase) lead to integrated concept of zonal and temporal steroid biosynthesis.
    Coulter CL; Jaffe RB
    Endocrinology; 1998 Dec; 139(12):5144-50. PubMed ID: 9832454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria.
    Cheng SC; Suzuki K; Sadee W; Harding BW
    Endocrinology; 1976 Oct; 99(4):1097-106. PubMed ID: 976190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human.
    Cerny MA; Csengery A; Schmenk J; Frederick K
    J Steroid Biochem Mol Biol; 2015 Nov; 154():197-205. PubMed ID: 26303746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatography methods for the separation and quantitation of spironolactone and its degradation products in aqueous formulations and of its metabolites in rat serum.
    Kaukonen AM; Vuorela P; Vuorela H; Mannermaa JP
    J Chromatogr A; 1998 Feb; 797(1-2):271-81. PubMed ID: 9542120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
    Steimer W; Müller C; Eber B
    Clin Chem; 2002 Mar; 48(3):507-16. PubMed ID: 11861441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
    Dasgupta A; Johnson MJ
    J Clin Lab Anal; 2010; 24(6):413-7. PubMed ID: 21089173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of [
    Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
    Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mineralocorticoid receptor function in treatment-resistant depression.
    Juruena MF; Pariante CM; Papadopoulos AS; Poon L; Lightman S; Cleare AJ
    J Psychopharmacol; 2013 Dec; 27(12):1169-79. PubMed ID: 23904409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH
    Takkis K; Aro R; Kõrgvee LT; Varendi H; Lass J; Herodes K; Kipper K
    Anal Bioanal Chem; 2017 May; 409(12):3145-3151. PubMed ID: 28224249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of canrenone to the actions of spironolactone on adrenal cytochrome P-450 dependent enzymes.
    Greiner JW; Rumbaugh RC; Kramer RE; Colby HD
    Endocrinology; 1978 Oct; 103(4):1313-20. PubMed ID: 311283
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved bioavailability and clinical response in patients with chronic liver disease following the administration of a spironolactone: beta-cyclodextrin complex.
    Abosehmah-Albidy AZ; York P; Wong V; Losowsky MS; Chrystyn H
    Br J Clin Pharmacol; 1997 Jul; 44(1):35-9. PubMed ID: 9241094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
    Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
    J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of aldosterone synthase cytochrome P450 (CYP11B2) and 11 beta-hydroxylase cytochrome P450 (CYP11B1) expression in rat adrenal zona glomerulosa cells by low sodium diet and angiotensin II receptor antagonists.
    Kakiki M; Morohashi K; Nomura M; Omura T; Horie T
    Biol Pharm Bull; 1997 Sep; 20(9):962-8. PubMed ID: 9331977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal mitochondrial metabolism of spironolactone. Absence of metabolic activation.
    Flowers NL; Sherry JH; O'Donnell JP; Colby HD
    Biochem Pharmacol; 1988 Apr; 37(8):1591-5. PubMed ID: 3358788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) genes are not expressed in the rat heart.
    Ye P; Kenyon CJ; MacKenzie SM; Jong AS; Miller C; Gray GA; Wallace A; Ryding AS; Mullins JJ; McBride MW; Graham D; Fraser R; Connell JM; Davies E
    Endocrinology; 2005 Dec; 146(12):5287-93. PubMed ID: 16179417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
    Dasgupta A; Tso G; Wells A
    Ther Drug Monit; 2008 Dec; 30(6):744-7. PubMed ID: 18824952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of spironolactone and its active metabolite canrenone in human plasma by HPLC-APCI-MS.
    Dong H; Xu F; Zhang Z; Tian Y; Chen Y
    J Mass Spectrom; 2006 Apr; 41(4):477-86. PubMed ID: 16541392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas.
    Fallo F; Pezzi V; Barzon L; Mulatero P; Veglio F; Sonino N; Mathis JM
    Eur J Endocrinol; 2002 Dec; 147(6):795-802. PubMed ID: 12457455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.